The RA BIODAM Program is an international collaborative network of 50 sites in 10 countries – a multi-centre, multi-national longitudinal observational study (LOS) – that explores the several soluble biomarkers for predicting structural damage in RA patients. The aim is the development of prognostic models in RA. developed by Dr. Walter P. Maksymowych.